Original Source(s)
Related Content
FDA approves amivantamab for head and neck cancer
Accelerated approval follows a 42% response rate in 102 patients previously treated with chemotherapy and immunotherapy.
by Mouj Hijazi
November 6, 2026
-
3 min
WHO 2026 global TB report: Mortality misses 2025 target
Global TB deaths fell 35% since 2015, well short of the targeted 75% reduction.
by Teraya Smith
November 12, 2026
-
3 min
May long COVID improve without full recovery?
Investigators found that symptom improvement remained possible years after infection, but patients with multisystem symptoms had lower likelihood of improvement.
November 3, 2026
-
4 min